The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Biotechnology
Guiyang Xintian Price, Forecast, Insider, Ratings, Fundamentals & Signals
2.27% CNY12.18
America/New_York / 6 mai 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 772.23 mill |
| EPS: | 0.330 |
| P/E: | 36.91 |
| Earnings Date: | Apr 27, 2024 |
| SharesOutstanding: | 227.61 mill |
| Avg Daily Volume: | 6.12 mill |
| RATING 2024-05-06 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.03x |
| Company: PE 36.91 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.26x |
| Company: PE 36.91 | industry: PE 29.29 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY-5.79 (-147.56%) CNY-17.97 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 11.35 - 12.55 ( +/- 5.00%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY12.18 (2.27% ) |
| Volume | 3.38 mill |
| Avg. Vol. | 6.12 mill |
| % of Avg. Vol | 55.27 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002873.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002873.SZ
Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of Chinese medicines for various diseases in China. The company offers formulation products, which include hard capsules, gels, mixtures, granules, and tablets. Its products are used for the treatment of antitumor, gynecological, urinary, breast thyroid, blood, heat, oral, anti-cold, and cardiovascular diseases. The company was founded in 1995 and is based in Guiyang, China.